N-Homolupinanoyl and N-(ω-lupinylthio)alkanoyl derivatives of some tricyclic systems as ligands for muscarinic M1 and M2 receptor subtypes

Farmaco

Volumn 58, Issue 9, 2003, Pages 669-676

  Tasso, Bruno ^a   Sparatore, Anna ^b   Sparatore, Fabio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Muscarinic receptors ligands; N (Homolupinanoyl)phenothiazines; N (tert Aminoalkanoyl)tricyclic systems; N ( lupinylthio)alkanoyl phenothiazines; Quinolizidine derivatives

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZYL DERIVATIVE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; NANOPARTICLE; PHENOTHIAZINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BRAIN CORTEX; DRUG SYNTHESIS; HEART; NONHUMAN; RAT; RECEPTOR AFFINITY;

EID: 0141453205     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(03)00104-6     Document Type: Article

References (26)

1. Eglen R.M., Hedge S.S., Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol. Rev. 48:1996;531-565.
2. Felder C.C., Bymaster F.P., Ward J., DeLapp N. Therapeutic opportunities for muscarinic receptors in the central nervous system. J. Med. Chem. 43:2000;4333-4353.
3. Eglen R.M., Choppin A., Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol. Sci. 22:2001;409-414.
4. Salamone J.D., Correa M., Carlson B.B., Wisniecki A., Mayorga A.J., Nisenbaum E., Nisenbaum L., Felder C. Neostriatal muscarinic receptor subtypes involved in the generation of tremulous jaw movements in rodents: implication for cholinergic involvement in Parkinsonism. Life Sci. 68:2001;2579-2584.
5. 2 antagonists as potential drugs for cognitive disorders. Drugs Fut. 20:1995;157-164.
6. Greenlee W., Clader J., Asberom T., McCombie S., Ford J., Guzik H., Kozlowski J., Li S., Liu C., Lowe D., Vice S., Zhao H., Zhou G., Billard W., Binch H., Crosby R., Duffy R., Lachowicz J., Coffin V., Watkins R., Ruperto V., Strader C., Taylor L., Cox K. Muscarinic agonists and antagonists in the treatment of Alzheimer's disease. Farmaco. 56:2001;247-250.
7. Sparatore A., Sparatore F. Preparation and pharmacological activities of 10-homolupinanoyl-2-R-phenothiazines. Farmaco. 49:1994;5-17.
8. Novelli F., Sparatore A., Tasso B., Sparatore F. Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors. Bioorg. Med. Chem. Lett. 9:1999;3031-3034.
9. Eberlein W.G., Engel W.W., Hasselbach K.M., Mayer N., Mihm G., Rudolf K., Doods H. Tricyclic compounds as selective muscarinic antagonists: structure-activity relationships and therapeutic implications. Angeli P., Gulini U., Quaglia W. Trends in Receptor Research. 1992;231-249 Elsevier, Amsterdam.
10. Dahlbom R., Ekstrand T. 10-Aminoacylphenothiazines. I. Aminoacetyl and aminopropionyl derivatives. Acta Chem. Scand. 5:1951;102-114.
11. Dahlbom R., Ekstrand T. 10-Aminoacylphenothiazines. II. Aminobutyryl derivatives. Acta Chem. Scand. 6:1952;1285-1288.
12. Dahlbom R., Edlund T., Ekstrand T., Lohi A. The activity of 10-aminoacylphenothiazine, basically substituted derivatives of phenothiazine-10-carboxylic acid, atropine, papaverine and some other spasmolytic drugs against barium and acetylcholine-induced spasms of guinea pig and rat ileum. Acta Pharmacol. Toxicol. 9:1953;168-178.
13. Dahlbom R. Studies on some phenothiazine derivatives. Sci. Repts. Ist. Super Sanit. 2:1962;309-319.
14. Dahlbom R., Diamant H., Edlund T., Ekstrand T., Holmstedt B. Protective effect of phenothiazine derivatives against poisoning by the irreversible cholinesterase inhibitor dimethylamido-ethoxyphosphoryl cyanide (Tabun). Acta Pharmacol. Toxicol. 9:1953;163-167.
15. K.B. Augustinsson, A titrimetric method for the determination of plasma and red cell cholinesterase activity, Scand. J. Clin. Lab. Invest. 7 (1955) 284-290 [Chem. Abstr. 50 (1956) 11408b].
16. Sparatore A., Veronese M., Sparatore F. Derivati chinolizidinici ad attività antimicrobica. Farmaco Ed. Sci. 42:1987;159-174.
17. Novelli F., Sparatore F. Thiolupinine and some derivatives of pharmacological interest. Farmaco. 48:1993;1021-1049.
18. F. Häfliger, W. Schindler, N-Acyl derivatives of iminodibenzyl, US Patent 2,666,051 (1954) [Chem. Abstr. 49 (1955) 9041f].
19. Ekstrand T. Phenothiazine derivatives of pharmacological interest. Acta Chem. Scand. 3:1949;302-303.
20. H.G. Morren, Substituted N-acylphenothiazines, Belg. Patent 586,033 (1960) [Chem. Abstr. 54 (1960) 18561e].
21. Société des usines chimiques Rhone-Poulenc, Phenothiazine derivatives, Brit. Patent 740,932 (1955) [Chem. Abstr. 51 (1957) 500i].
22. F. Kazutoshi, S. Atsuo, S. Kazuo, O. Kazuo, 10-Chloroacetylphenothiazine, Japan Patent 74,27,191 [Chem. Abstr. 82 (1975) 140161w].
23. Toldy L., Toth I., Fekete M., Borsy J. Phenothiazine derivatives. VI. Experiments for the preparation of phenothiazines with selective coronary dilator activity. Acta Chim. Acad. Sci. Hung. 44:1965;301-325.
24. Hromatka O., Schlager L.H., Sauter F. Phenothiazine derivatives. IV. Synthesis of 10-(piperazinoacyl)phenothiazines. Monatsh. 88:1957;234-241.
25. Ellman G.L., Courtney K.D., Andres V. Jr., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
26. 2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur. J. Pharmacol. 151:1988;205-221.